Malignant Respiratory System Neoplasm — Trials

Malignant Respiratory System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,492)

clinicaltrialsPublishedShowing 401–450 of 1,697 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05898594	Lung Cancer Screening in High-risk Black Individuals	recruiting	N/A	900	Massachusetts General HospitalOTHER	1	Feb 23, 2026	clinicaltrials
NCT06552000	Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer	not yet recruiting	N/A	18	University of Texas Southwestern Medical CenterOTHER	1	Feb 23, 2026	clinicaltrials